Hep Email Update
FDA Approves First-Ever Drug for Fatty Liver Disease
People who used resmetirom (Rezdiffra) in a late-stage clinical trial experienced both MASH resolution and fibrosis improvement.
What Is Fatty Liver Disease? (MASLD and MASH)
Get the basics!
What are the complications of fatty liver disease?
MASLD and MASH can lead to liver fibrosis, cirrhosis and liver cancer.
Advertisement
Grant to Support Liver Disease Drug Development, Potentially Reduce Animal Testing
A $7.8 million federal grant will fund a new drug discovery center at the University of Pittsburgh. Research will initially focus on MASLD.
Semaglutide Reduces Liver Fat in People Living With HIV
The diabetes and weight-loss drug also appears to improve biomarkers of inflammation and immune activation.
#fatty liver disease
Get all the latest updates!
Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2024 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.